Leonard Greenstein
Equibles does not estimate personal net worth.
Get an email with a short summary when Tarsus Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get TARS alertsAbout Leonard Greenstein
Leonard Greenstein is recorded as CFO at Tarsus Pharmaceuticals, Inc. (TARS). The proxy statement of Tarsus Pharmaceuticals, Inc. reports total compensation of $1,978,579 for Leonard Greenstein in fiscal 2023, including a base salary of $202,100. Tarsus Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Tarsus Pharmaceuticals, Inc. includes Bobak Azamian (CEO and Chairman), Jeffrey S. Farrow (CFO), Seshadri Neervannan (COO) and 7 others.
Affiliation history
-
Current
Company network
Leadership on record at Tarsus Pharmaceuticals, Inc.
- Bobak Azamian CEO, Chairman
- Jeffrey S. Farrow CFO
- Seshadri Neervannan COO
- Bryan Wahl General Counsel
- Andrew Goldberg Board Member
- Bhaskar Chaudhuri Board Member
- David E.I. Pyott Board Member
- Elizabeth Yeu-Lin, M.D. Board Member
- Katherine Goodrich Board Member
- Rosemary A. Crane Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Financial Officer | $202,100 | $1,978,579 |
Recent activity
No call appearances or filed executive changes recorded yet.